CoChat

Lysosome restoration to activate podocyte autophagy: a new therapeutic strategy for diabetic kidney disease

Open access
Liu, Wei Jing, Gan, Yu, Huang, Wei Fang, Wu, Hong-luan, Zhang, Xue-qin, Zheng, Hui Juan, Liu, Hua-feng · 2019 · Cell Death & Disease

The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.

Abstract

Autophagy, the intracellular lysosomal degradation process plays a pivotal role in podocyte homeostasis in diabetic kidney disease (DKD). Lysosomal function, autophagic activity, and their actions were investigated in vitro and in vivo. We found that LC3-II- and p62-positive vacuoles accumulated in podocytes of patients with DKD. Moreover, we found that advanced glycation end products (AGEs) could increase the protein expression of LC3-II and p62 in a dose- and time-dependent manner in cultured podocytes. However, the mRNA expression of LC3B, Beclin-1 or ATG7, as well as the protein level of Beclin-1 or ATG7 did not change significantly in the AGE-treated cells compared with that in control groups, suggesting that AGEs did not induce autophagy. In addition, AGEs led to an increase in the number of autophagosomes but not autolysosomes, accompanied with a failure in lysosomal turnover of LC3-II or p62, indicating that the degradation of autophagic vacuoles was blocked. Furthermore, we observed a dramatic decrease in the enzymatic activities, and the degradation of DQ-ovalbumin was significantly suppressed after podocytes were treated with AGEs. Plasma-irregular lysosomal-associated membrane protein 1 granules accompanied with the diffusion of cathepsin D expression and acridine orange redistribution were observed in AGE-treated podocytes, indicating that the lysosomal membrane permeability was triggered. Interestingly, we also found that AGEs-induced autophagic inhibition and podocyte injury were mimicked by the specific lysosomotropic agent, l-leucyl-l-leucine methyl ester. The exacerbated apoptosis and Rac-1-dependent actin-cytoskeletal disorganization were alleviated by an improvement in the lysosomal-dependent autophagic pathway by resveratrol plus vitamin E treatment in AGE-treated podocytes. However, the rescued effects were reversed by the addition of leupeptin, a lysosomal inhibitor. It suggests that restoring lysosomal function to activate autophagy may contribute to the development of new therapeutic strategies for DKD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41419-019-2002-6

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 An accumulation of LC3-II in podocytes in patients with DKD. a Representative images of immunofluorescence assays of LC3 (green) in podocytes on kidney biopsy specimens from DKD patients (patients 1–5) and controls (controls 1–5). The podocytes in glomeruli were identified by synaptopodin (red), a podocyte-specific protein. The nuclei were stained with DAPI (blue). White arrows indicate the expression of LC3-positive puncta in podocytes. Scale bar, 25 μm. b The score of LC3-II expression in podocytes of DKD patients and controls. The expression of LC3-II was increased in podocytes in patients with DKD
Fig. 1 An accumulation of LC3-II in podocytes in patients with DKD. a Representative images of immunofluorescence assays of LC3 (green) in podocytes on kidney biopsy specimens from DKD patients (patients 1–5) and controls (controls 1–5). The podocytes in glomeruli were identified by synaptopodin (red), a podocyte-specific protein. The nuclei were stained with DAPI (blue). White arrows indicate the expression of LC3-positive puncta in podocytes. Scale bar, 25 μm. b The score of LC3-II expression in podocytes of DKD patients and controls. The expression of LC3-II was increased in podocytes in patients with DKDCC BY · PubMed Central
Fig. 2 Quantitative changes of autophagic vacuoles after exposure of podocytes to AGE-BSA at different concentrations for different times. a, e Immunofluorescence staining of LC3 in podocytes after exposure to AGE-BSA at different concentrations and times. Scale bar, 10 μm. c, g Western blot analysis of LC3. b, d, f, h Densitometry was performed for the quantification, and the ratio of LC3-II to tubulin was expressed as the fold-change compared with the level in the control. i Ultrastructural images of autophagic vacuoles and mitochondria after exposure of podocytes to AGE-BSA for 12 h. Arrow indicates the autophagic vacuole. AGE-BSA induced the accumulation of autophagic vacuoles in a concentration- and time-dependent manner. *p < 0.05; **p < 0.01; ***p < 0.001
Fig. 2 Quantitative changes of autophagic vacuoles after exposure of podocytes to AGE-BSA at different concentrations for different times. a, e Immunofluorescence staining of LC3 in podocytes after exposure to AGE-BSA at different concentrations and times. Scale bar, 10 μm. c, g Western blot analysis of LC3. b, d, f, h Densitometry was performed for the quantification, and the ratio of LC3-II to tubulin was expressed as the fold-change compared with the level in the control. i Ultrastructural images of autophagic vacuoles and mitochondria after exposure of podocytes to AGE-BSA for 12 h. Arrow indicates the autophagic vacuole. AGE-BSA induced the accumulation of autophagic vacuoles in a concentration- and time-dependent manner. *p < 0.05; **p < 0.01; ***p < 0.001CC BY · PubMed Central
Fig. 3 Quantitative changes of protein or mRNA level of Beclin-1 and ATG7 in podocytes from DKD patients and after exposure to AGE-BSA. a, b Representative images of immunofluorescence assays of Beclin 1 or ATG7 (green) in podocytes on kidney biopsy specimens from DKD patients and controls. The podocytes in glomeruli were identified by synaptopodin (red). The nuclei were stained with DAPI (blue). c, d The score of Beclin 1 or ATG7 expression in podocytes of DKD patients and controls. e Immunofluorescence staining of Beclin 1 or ATG7 after exposure of podocytes to AGE-BSA at 100 μg/ml for 12 h. f, g Mean fluorescence intensity of Beclin 1 or ATG7 was measured for both groups. h Western blot analysis of Beclin 1 or ATG7. i, j Densitometry was performed for the quantification, and the ratio of Beclin 1 or ATG7 to β-actin was expressed as the fold-change to 0 h. k, l, m The relative mRNA expressions of Beclin-1 (k), ATG7 (l), and LC3B (m) after exposure to AGE-BSA for 3, 6, 12, and 24 h. There was no significant difference observed among all the groups. Scale bar, 20 μm; ns, no significance
Fig. 3 Quantitative changes of protein or mRNA level of Beclin-1 and ATG7 in podocytes from DKD patients and after exposure to AGE-BSA. a, b Representative images of immunofluorescence assays of Beclin 1 or ATG7 (green) in podocytes on kidney biopsy specimens from DKD patients and controls. The podocytes in glomeruli were identified by synaptopodin (red). The nuclei were stained with DAPI (blue). c, d The score of Beclin 1 or ATG7 expression in podocytes of DKD patients and controls. e Immunofluorescence staining of Beclin 1 or ATG7 after exposure of podocytes to AGE-BSA at 100 μg/ml for 12 h. f, g Mean fluorescence intensity of Beclin 1 or ATG7 was measured for both groups. h Western blot analysis of Beclin 1 or ATG7. i, j Densitometry was performed for the quantification, and the ratio of Beclin 1 or ATG7 to β-actin was expressed as the fold-change to 0 h. k, l, m The relative mRNA expressions of Beclin-1 (k), ATG7 (l), and LC3B (m) after exposure to AGE-BSA for 3, 6, 12, and 24 h. There was no significant difference observed among all the groups. Scale bar, 20 μm; ns, no significanceCC BY · PubMed Central
Fig. 4 An accumulation of p62 in podocytes in patients with DKD. a Representative images of immunofluorescence assays of p62 (green) and synaptopodin (red) proteins in kidney biopsy specimens from a patient with DKD (patient 1–4) and controls (control 1–4). The nuclei were stained with DAPI (blue). White arrows indicate the expression of p62 in podocytes. Scale bar, 25 μm. b The score of p62 expression in podocytes of DKD patients and controls. Compared to controls, the expression of p62 was increased in podocytes in patients with DKD
Fig. 4 An accumulation of p62 in podocytes in patients with DKD. a Representative images of immunofluorescence assays of p62 (green) and synaptopodin (red) proteins in kidney biopsy specimens from a patient with DKD (patient 1–4) and controls (control 1–4). The nuclei were stained with DAPI (blue). White arrows indicate the expression of p62 in podocytes. Scale bar, 25 μm. b The score of p62 expression in podocytes of DKD patients and controls. Compared to controls, the expression of p62 was increased in podocytes in patients with DKDCC BY · PubMed Central
Fig. 5 Quantitative changes in autophagy substrate after exposure of podocytes to AGE-BSA at different concentrations for different times. a, e Immunofluorescence staining of p62 in podocytes after exposure to AGE-BSA at different concentrations and times. b, f Mean fluorescence intensity of p62 was measured for different groups. c, g Western blot analysis of p62. d, h Densitometry was performed for the quantification, and the ratio of p62 to tubulin was expressed as the fold-change compared with the level in the control. The expression of p62 was enhanced in a dose- and time-dependent manner after exposure to AGE-BSA. Scale bar, 10 μm. *p < 0.05; **p < 0.01; ***p < 0.001
Fig. 5 Quantitative changes in autophagy substrate after exposure of podocytes to AGE-BSA at different concentrations for different times. a, e Immunofluorescence staining of p62 in podocytes after exposure to AGE-BSA at different concentrations and times. b, f Mean fluorescence intensity of p62 was measured for different groups. c, g Western blot analysis of p62. d, h Densitometry was performed for the quantification, and the ratio of p62 to tubulin was expressed as the fold-change compared with the level in the control. The expression of p62 was enhanced in a dose- and time-dependent manner after exposure to AGE-BSA. Scale bar, 10 μm. *p < 0.05; **p < 0.01; ***p < 0.001CC BY · PubMed Central
Fig. 6 LC3 or p62 turnover assay in vitro. a, b Immunofluorescence analysis of LC3 and the differences in LC3-II puncta between samples with and without bafilomycin A1 (Baf A1), leupeptin (LEU), and chloroquine (CQ) were compared after exposure to AGE-BSA or Co-BSA. LC3-II turnover (comparing lanes 5, 6, 7, and 8 with 4) was not observed after exposure to AGE-BSA. c, d Western blot analysis of LC3 and the difference in the LC3-II levels between samples with and without Baf A1, LEU, and CQ was compared after exposure to AGE-BSA or Co-BSA. e, f Immunofluorescence analysis of p62 and the difference in the mean fluorescence intensity between samples with and without Baf A1, LEU, and CQ was compared after exposure to AGE-BSA or Co-BSA. P62 turnover (comparing lanes 5, 6, 7, and 8 with 4) was not observed after exposure to AGE-BSA. g, h Western blot analysis of p62 and the difference in the p62 levels between samples with and without Baf A1, LEU, and CQ was compared after exposure to AGE-BSA or Co-BSA. Scale bar, 10 μm. *p < 0.05, **p < 0.01, and ***p < 0.001
Fig. 6 LC3 or p62 turnover assay in vitro. a, b Immunofluorescence analysis of LC3 and the differences in LC3-II puncta between samples with and without bafilomycin A1 (Baf A1), leupeptin (LEU), and chloroquine (CQ) were compared after exposure to AGE-BSA or Co-BSA. LC3-II turnover (comparing lanes 5, 6, 7, and 8 with 4) was not observed after exposure to AGE-BSA. c, d Western blot analysis of LC3 and the difference in the LC3-II levels between samples with and without Baf A1, LEU, and CQ was compared after exposure to AGE-BSA or Co-BSA. e, f Immunofluorescence analysis of p62 and the difference in the mean fluorescence intensity between samples with and without Baf A1, LEU, and CQ was compared after exposure to AGE-BSA or Co-BSA. P62 turnover (comparing lanes 5, 6, 7, and 8 with 4) was not observed after exposure to AGE-BSA. g, h Western blot analysis of p62 and the difference in the p62 levels between samples with and without Baf A1, LEU, and CQ was compared after exposure to AGE-BSA or Co-BSA. Scale bar, 10 μm. *p < 0.05, **p < 0.01, and ***p < 0.001CC BY · PubMed Central
Fig. 7 Quantitative changes in autophagosomes and autolysosomes in podocytes after exposure to AGE-BSA. a Fluorescence microscopic analysis of podocytes transfected with plasmid constructs harboring LC3 fused with a tandem mRFP-GFP tag (tfLC3) and treated with Co-BSA, AGE-BSA (100 μg/ml), or rapamycin (RAP, 10 μM) for 12 h. b Quantitative data for green or red puncta per cell. c Quantitative data for yellow puncta or free red puncta per cell. The yellow puncta, which showed GFP and mRFP fluorescence signals, indicated autophagosomes that were not fused with lysosomes (arrowheads). The free red puncta indicate autolysosomes (arrows) where the GFP signal was quenched under acidic conditions. Compared with the control podocytes, the AGE-BSA-treated podocytes showed much more yellow puncta. However, podocytes exposed to RAP displayed increased autolysosomes. Scale bar, 10 μm. *p < 0.05 (for green or red puncta); #p < 0.05 (for free red puncta)
Fig. 7 Quantitative changes in autophagosomes and autolysosomes in podocytes after exposure to AGE-BSA. a Fluorescence microscopic analysis of podocytes transfected with plasmid constructs harboring LC3 fused with a tandem mRFP-GFP tag (tfLC3) and treated with Co-BSA, AGE-BSA (100 μg/ml), or rapamycin (RAP, 10 μM) for 12 h. b Quantitative data for green or red puncta per cell. c Quantitative data for yellow puncta or free red puncta per cell. The yellow puncta, which showed GFP and mRFP fluorescence signals, indicated autophagosomes that were not fused with lysosomes (arrowheads). The free red puncta indicate autolysosomes (arrows) where the GFP signal was quenched under acidic conditions. Compared with the control podocytes, the AGE-BSA-treated podocytes showed much more yellow puncta. However, podocytes exposed to RAP displayed increased autolysosomes. Scale bar, 10 μm. *p < 0.05 (for green or red puncta); #p < 0.05 (for free red puncta)CC BY · PubMed Central
Fig. 8 Effects of AGE-BSA on enzymatic activity and lysosomal degradation of DQ-ovalbumin in podocytes. a Markedly decreased proteolytic activity of cathepsin B, cathepsin D, and cathepsin L in podocytes after exposure to AGE-BSA for different times. b, c Cleaved fluorescent DQ-ovalbumin (green) obviously dropped in podocytes after exposure to AGE-BSA for 0, 3, 6, 12, 24, or 36 h. d, e The mean fluorescence intensity of the DQ-ovalbumin signal was significantly decreased after exposure to AGE-BSA for different times, as analyzed by flow cytometry. Scale bar, 10 μm; *p < 0.05; **p < 0.01; ***p < 0.001
Fig. 8 Effects of AGE-BSA on enzymatic activity and lysosomal degradation of DQ-ovalbumin in podocytes. a Markedly decreased proteolytic activity of cathepsin B, cathepsin D, and cathepsin L in podocytes after exposure to AGE-BSA for different times. b, c Cleaved fluorescent DQ-ovalbumin (green) obviously dropped in podocytes after exposure to AGE-BSA for 0, 3, 6, 12, 24, or 36 h. d, e The mean fluorescence intensity of the DQ-ovalbumin signal was significantly decreased after exposure to AGE-BSA for different times, as analyzed by flow cytometry. Scale bar, 10 μm; *p < 0.05; **p < 0.01; ***p < 0.001CC BY · PubMed Central
Fig. 9 Effect of AGE-BSA on acridine orange distribution. a After exposure to 100 μg/ml AGE-BSA, podocytes were stained with acridine orange and viewed under a microscope. Concomitant with the increase of green fluorescence, a conspicuous reduction of red fluorescence was observed in podocytes treated with AGE-BSA. b Quantitative data for the mean fluorescence intensity of red or green signal. Scale bar, 10 μm. ***p < 0.001
Fig. 9 Effect of AGE-BSA on acridine orange distribution. a After exposure to 100 μg/ml AGE-BSA, podocytes were stained with acridine orange and viewed under a microscope. Concomitant with the increase of green fluorescence, a conspicuous reduction of red fluorescence was observed in podocytes treated with AGE-BSA. b Quantitative data for the mean fluorescence intensity of red or green signal. Scale bar, 10 μm. ***p < 0.001CC BY · PubMed Central
Fig. 10 Changes in the distribution of cathepsin D (CD) and LAMP1 in podocytes after exposure to AGE-BSA. Immunofluorescence staining of LAMP1 and cathepsin D (CD) in podocytes after exposure to 100 μg/ml AGE-BSA for 0, 3, 6, 12, or 36 h. The red immunofluorescence showed the leakage of CD from lysosomes into the cytoplasm that was accompanied by dispersed LAMP1 (green fluorescence). Scale bar, 10 μm
Fig. 10 Changes in the distribution of cathepsin D (CD) and LAMP1 in podocytes after exposure to AGE-BSA. Immunofluorescence staining of LAMP1 and cathepsin D (CD) in podocytes after exposure to 100 μg/ml AGE-BSA for 0, 3, 6, 12, or 36 h. The red immunofluorescence showed the leakage of CD from lysosomes into the cytoplasm that was accompanied by dispersed LAMP1 (green fluorescence). Scale bar, 10 μmCC BY · PubMed Central
Fig. 11 Effects of LLOMe on autophagy and cellular injury after exposure of podocytes to AGE-BSA. a, c Immunofluorescence staining of LC3 or p62 in podocytes after exposure to LLOMe. b, d Quantification of LC3 or p62 expression after exposure of podocytes to LLOMe. LLOMe induced an accumulation of LC3 or p62 in podocytes. e Fluorescence microscopic analysis of podocytes transfected with tfLC3 and treated with LLOMe. f Quantitative data for green or red puncta per cell. g Quantitative data for yellow puncta or free red puncta per cell. Autophagosomes (arrowheads), but not autolysosomes (arrows) were increased after exposure to LLOMe. h Immunofluorescence of F-actin cytoskeleton (green) showed loss of stress fibers and cortical actin staining after exposure of podocytes to LLOMe. i Quantification of the phalloidin staining. j The activity of caspase-3 was increased after exposure of podocytes to LLOMe. Scale bar, 10 μm
Fig. 11 Effects of LLOMe on autophagy and cellular injury after exposure of podocytes to AGE-BSA. a, c Immunofluorescence staining of LC3 or p62 in podocytes after exposure to LLOMe. b, d Quantification of LC3 or p62 expression after exposure of podocytes to LLOMe. LLOMe induced an accumulation of LC3 or p62 in podocytes. e Fluorescence microscopic analysis of podocytes transfected with tfLC3 and treated with LLOMe. f Quantitative data for green or red puncta per cell. g Quantitative data for yellow puncta or free red puncta per cell. Autophagosomes (arrowheads), but not autolysosomes (arrows) were increased after exposure to LLOMe. h Immunofluorescence of F-actin cytoskeleton (green) showed loss of stress fibers and cortical actin staining after exposure of podocytes to LLOMe. i Quantification of the phalloidin staining. j The activity of caspase-3 was increased after exposure of podocytes to LLOMe. Scale bar, 10 μmCC BY · PubMed Central
Fig. 12 Effects of resveratrol plus vitamin E and leupeptin on autophagic-lysosomal pathway and cellular injury after exposure of podocytes to AGE-BSA. a, b The proteolytic activities of cathepsin B and cathepsin L were increased by resveratrol plus vitamin E treatment, which were blocked by leupeptin, in podocytes after exposure to AGE-BSA. c, d The accumulation of LC3-II or p62 was decreased by resveratrol plus vitamin E treatment, which was blocked by leupeptin, in podocytes after exposure to AGE-BSA. e, g The mean fluorescence intensity of the DQ-ovalbumin signal was enhanced by resveratrol plus vitamin E treatment, which was blocked by leupeptin, in podocytes after exposure to AGE-BSA. f Immunofluorescence of F-actin cytoskeleton (green) showed that the disrupted actin cytoskeleton was normalized by resveratrol plus vitamin E treatment, which was blocked by leupeptin, in podocytes after exposure to AGE-BSA. h The activity of caspase-3 was deceased due to the resveratrol plus vitamin E treatment, which was blocked by leupeptin, in podocytes after exposure to AGE-BSA. i Quantification of the phalloidin staining. j, k Rac-1 activity, but not RhoA activity, was decreased in AGE-BSA-treated cells, which could be rescued by resveratrol plus vitamin E treatment. Scale bar, 10 μm. *p < 0.05, **p < 0.01, ***p < 0.001
Fig. 12 Effects of resveratrol plus vitamin E and leupeptin on autophagic-lysosomal pathway and cellular injury after exposure of podocytes to AGE-BSA. a, b The proteolytic activities of cathepsin B and cathepsin L were increased by resveratrol plus vitamin E treatment, which were blocked by leupeptin, in podocytes after exposure to AGE-BSA. c, d The accumulation of LC3-II or p62 was decreased by resveratrol plus vitamin E treatment, which was blocked by leupeptin, in podocytes after exposure to AGE-BSA. e, g The mean fluorescence intensity of the DQ-ovalbumin signal was enhanced by resveratrol plus vitamin E treatment, which was blocked by leupeptin, in podocytes after exposure to AGE-BSA. f Immunofluorescence of F-actin cytoskeleton (green) showed that the disrupted actin cytoskeleton was normalized by resveratrol plus vitamin E treatment, which was blocked by leupeptin, in podocytes after exposure to AGE-BSA. h The activity of caspase-3 was deceased due to the resveratrol plus vitamin E treatment, which was blocked by leupeptin, in podocytes after exposure to AGE-BSA. i Quantification of the phalloidin staining. j, k Rac-1 activity, but not RhoA activity, was decreased in AGE-BSA-treated cells, which could be rescued by resveratrol plus vitamin E treatment. Scale bar, 10 μm. *p < 0.05, **p < 0.01, ***p < 0.001CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Cited by

See all 89

Metadata

Authors
Liu, W. J., Gan, Y., Huang, W. F., Wu, H.-L., Zhang, X.-Q., Zheng, H. J., & Liu, H.-F.
Affiliations
Guangdong Medical College (CN)
Venue
Cell Death & Disease
Published
2019-10-24
Volume
10
Issue
11
Pages
806-806
ISSN
2041-4889 (ISSN-L)
OpenAlex
W2982228087
Cited by
88
References
51
Citations by year
2026: 7 · 2025: 10 · 2024: 21 · 2023: 6 · 2022: 18 · 2021: 18 · 2020: 8
FWCI
8.37
Type
journal article
Language
en
Open access
Licence
Locations
  • Cell Death and Disease (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
National Natural Science Foundation of China (81570656)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Keywords
diabetic nephropathy, podocytes, autophagy, lysosomal dysfunction, advanced glycation end products, LC3-II, p62, autophagosomes, lysosomal membrane permeability, lysosomotropic agents, resveratrol, vitamin E, Rac1, actin cytoskeleton, podocyte injury, LAMP1
MeSH terms
Autophagy, Diabetic Nephropathies, Humans, Lysosomes, Podocytes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lysosome restoration to activate podocyte autophagy: a new therapeutic strategy for diabetic kidney disease. https://app.cochat.ai/papers/10.1038/s41419-019-2002-6
The paper
Liu, W. J., Gan, Y., Huang, W. F., Wu, H.-L., Zhang, X.-Q., Zheng, H. J., & Liu, H.-F. (2019). Lysosome restoration to activate podocyte autophagy: a new therapeutic strategy for diabetic kidney disease. Cell Death & Disease. https://doi.org/10.1038/s41419-019-2002-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.